Background. We investigated the changes in adherens junction proteins, such as vascular endothelialcadherin and b-catenin, of skeletal muscle and vessels in patients with or without diabetes in the setting of cardiopulmonary bypass and cardiac operation. Methods. Skeletal muscle tissue samples were harvested pre-and post-cardiopulmonary bypass from nondiabetic (hemoglobin A1c: 5.4 ± 0.1), controlled diabetic (hemoglobin A1c: 6.3 ± 0.1), and uncontrolled diabetic patients (hemoglobin A1c: 9.6 ± 0.3) undergoing coronary artery bypass grafting operation (n = 8 per group). The expression/phosphorylation of adherens junction proteins vascular endothelial-cadherin and b-catenin were assessed by immunoblotting and immuno-histochemistry. Endothelial function of skeletal muscle arterioles was determined by videomicroscopy in response to the vasodilator substance P. Results. The protein expression of total vascular endothelial-cadherin was not changed at baseline or between pre-and post-cardiopulmonary bypass among groups. The pre-cardiopulmonary bypass level of phosphovascular endothelial-cadherin was found to be significantly increased in the uncontrolled diabetic patients group compared with the nondiabetic or controlled diabetic groups (P < .05). The post-cardiopulmonary bypass levels of phospho-vascular endothelial-cadherin were significantly increased compared with precardiopulmonary bypass in all groups (P < .05 each), and this increase was greater in the uncontrolled diabetic patients group than that of the nondiabetic or controlled diabetic groups (P < .05). Expression of basal b-catenin protein in the uncontrolled diabetic group was decreased compared with nondiabetic or controlled diabetic groups (P < .05). There were significant decreases in the b-catenin protein expression between pre-and post-cardiopulmonary bypass in all 3 groups (P <.05 each), and this decrease was greater in the uncontrolled diabetic patients group than the nondiabetic group (P <.05). There were decreases in the relaxation response of skeletal muscle arterioles to substance P after cardiopulmonary bypass in all 3 groups (P < .05), and this alteration was more pronounced in the uncontrolled diabetic patients (P < .05). Conclusion. Uncontrolled diabetes causes inactivation and reduction in the expression of endothelial adherens junction proteins in the arterioles of skeletal muscle early after cardiopulmonary bypass. The enhanced phosphorylation of vascular endothelial-cadherin and degradation of b-catenin indicate deterioration of these proteins and damage of the cell-cell endothelial junctions, specifically in the diabetic peripheral vessels. These alterations may contribute to the increases in peripheral vascular permeability and endothelial dysfunction. (Surgery 2017;161:823-9.) 
CARDIOPULMONARY BYPASS (CPB) is often associated with increased vascular permeability, microvascular endothelial cell injury/dysfunction, and decreased peripheral vasomotor tone, manifested as postoperative systemic hypotension and tissue edema. [1] [2] [3] [4] [5] In particular, these disturbances are more pronounced in the uncontrolled diabetic patients. [1] [2] [3] [4] [5] These effects can be attributed to CPB-induced systemic inflammation and increased expression of vascular endothelial growth factor (VEGF) and vascular permeability factor. 1, 6, 7 These alterations may contribute to an increased duration of stay and worse outcomes in uncontrolled diabetic patients after cardiac operation. 1, [6] [7] [8] The mechanisms responsible for CPB-initiated peripheral vascular permeability need to be defined further. Recently, we demonstrated that the increased permeability after cardioplegic ischemia/reperfusion is associated with changes in the expression/phosphorylation of adherens junction proteins of the coronary microvasculature in uncontrolled diabetic patients. 8 Therefore, we hypothesized that diabetes may also cause downregulation of adherence-junction-proteins in peripheral tissues such as the arterioles of skeletal muscle early after CPB. Thus, the aims of the present study were to determine the role of diabetes in expression of selected proteins (vascular endothelial [VE]-cadherin and b-catenin) in adherensjunctions in human skeletal muscle and peripheral microvasculature and to investigate the effects of diabetes on arteriolar endothelial function in the setting of CPB and cardiac operation.
METHODS
Human subjects and tissue harvesting. Samples of skeletal muscle from the left intercostal muscle bed were harvested pre-and post-CPB from 100 patients undergoing coronary artery bypass grafting. Hemoglobin A1C (HgbA1c) was measured in all patients. The patients were divided into the following 3 groups: (1) patients with a normal HgbA1c and no history or treatment for diabetes were considered nondiabetic (ND); (2) patients with a history of diabetes with a HgbA1c >5.5 but #7 were considered well controlled (CDM); and (3) diabetic patients with a HgbA1c $8.5 were considered uncontrolled (UDM). Patients who also underwent valve operation were excluded from the study. Although there is no definitive HgbA1c level that is universally accepted as a marker for poorly controlled diabetes, an HgbA1C of #7 is regarded generally as a marker of well-controlled diabetes, and HgbA1C >7 is generally regarded as less well controlled; an HgbA1C of 8.5 is indicative of poorly controlled diabetes.
Eight randomly chosen patients in each of 3 groups from 100 cases were included for analysis in this study. The first sample of skeletal muscle in the left intercostal muscle bed was harvested after cannulation before CPB (pre-CPB), and the second sample of skeletal muscle was obtained after removal of the aortic cross-clamp and weaning from CPB (post-CPB). 2 Tissue samples were frozen immediately in liquid nitrogen or stored immediately in 10% formalin for immunoblot analysis and immunofluorescent staining. Tissue samples for microvascular reactivity were stored immediately in cold (5-108C) Krebs buffer solution. 2 All procedures were approved by the Institutional Review Board of Rhode Island Hospital, Alpert Medical School of Brown University, and informed consent was obtained from all enrolled patients.
Immunoblot. The methods for tissue protein purification, Western blotting, and imaging quantification have been described previously. [2] [3] [4] [5] 8 Membranes were incubated overnight at 48C with primary antibodies against VE-cadherin (Cell Signaling, Danvers, MA), phospho-VE-cadherin (Y685), and b-catenin (ABCAM, Cambridge, MA). After washing with TBST, membranes were incubated with the appropriate secondary antibody conjugated to horseradish peroxidase. All membranes were also incubated with GAPDH (glyceraldehyde-3-phosphate, Cell Signaling) for loading controls.
Immunofluorescence microscopy. The detailed methods have been described previously. [2] [3] [4] 8 After PBS wash, tissue sections of skeletal muscle were incubated overnight with anti-phospho-VEcadherin antibody (LifeSpan BioScience, Inc, Seattle, WA) and/or anti-smooth muscle a-actin antibody at 48C (Cell Signaling). The tissue sections were finally mounted with VECTA-SHIELD Mounting Medium with DAPI (49,6-diamidino-2-phenylindole; Vector Laboratories, Burlingame, CA).
Microvessel reactivity. Arterial microvessels (100-180 mm internal diameters, n = 8 per group) were dissected from skeletal muscle samples taken pre-and post-CPB. Microvessel studies were performed in vitro in a pressurized (40 mm Hg) noflow state using video-microscopy as previously described. [2] [3] [4] [5] 8 The vessel was precontracted with thromboxane analog U46619 (3 3 10 À6 M to 10 À7 M) to achieve 30-40% of baseline diameter. Substance P (10 À12 M to 10 À7 M) was added to the organ bath and diameter measurements were taken. We have determined previously that the response of human coronary and peripheral arterioles to substance P is endothelium-dependent.
2-4,8
Chemicals. U46619 and substance P were purchased from Sigma-Aldrich (St. Louis, MO).
Data analysis. All statistical analysis were performed with GraphPad Software (GraphPad Software, Inc, San Diego, CA). Data are expressed as the mean and standard error of the mean (mean ± SEM). For analysis of data from patient characteristics, protein expression, and other imaging, Kruskal-Wallis tests with Dunn's multiple test were performed. For analysis of categorical data, Fisher exact test was used. For analysis of There were no differences in total VE-cadherin protein expression in the human skeletal muscle harvested pre-and post-CPB. (C and D) There were significant increases in expression of phospho-VE-cadherin (Y685) after CPB among 3 groups; these effects were more pronounced in the UDM group compared with the ND or CDM groups; *P < .05 versus pre-CPB; @P < .05 versus ND-or CDM-pre-CPB; #P < .05 versus ND-or CDM-post-CPB; mean ± SEM, n = 8 per group. 
RESULTS
Patient characteristics. The characteristics of the 24 enrolled patients are shown in Table I . All patients with preoperative hypertension were treated with antihypertensive medications (b-blocker, calcium channel blocker, or angiotensin-converting enzyme inhibitor). The levels of preoperative blood HgbA1c were 5.4 ± 0.1 in the ND patients, 6.3 ± 0.1 in the CDM patients, and 9.3 ± 0.3 in the UDM patients (P < .05).
Effect of CPB on levels of VE-cadherin, phospho-VE-cadherin, and b-catenins. The protein expression of total VE-cadherin was not changed at baseline or between pre-and post-CPB among groups (Fig 1, A and B ). The pre-CPB level of phospho-VE-cadherin was found to be significantly increased in the UDM group compared with the ND or CDM groups (P = .001, Fig 1, C and D) . The post-CPB levels of phospho-VE-cadherin were significantly increased compared with pre-CPB in all groups (ND: P #.03 each). This increase was greater in the UDM group than that of the ND or CDM groups (P <.05, Fig 1, C and D) . Before CPB, the total amount of b-catenin protein was found to be unchanged between ND and CDM groups (Fig 2, A and  B) . Expression of basal b-catenin protein in UDM group was decreased compared with ND or CDM (P < .05). There were significant decreases in the b-catenin protein expression between pre-and post-CPB in all 3 groups (P < .05 each). This decrease was greater in the UDM group than the ND group (P < .05, Fig 2) .
Vascular distribution of phospho-VE-cadherin. Immunofluorescent staining of phospho-VEcadherin was observed in the arteriolar endothelial cells (red, Fig 3, A and B) . At baseline (pre-CPB), phospho-VE-cadherin immunofluorescence was increased significantly in the UDM vessels compared with the ND and CDM groups. There were no significant differences in the pre-CPB levels of phospho-VE-cadherin immunofluorescence in vessels between ND and CDM. After CPB, phospho-VE-cadherin immunofluorescence were significantly increased compared with pre-CPB in all 3 groups, but this increase was greater in the UDM group than that of ND or CDM groups (P < .05 each , Fig 3, B) .
Microvascular reactivity. Table II shows no significant differences in the arteriolar baseline diameters between groups. The percentage of precontraction were 33 ± 4%, 31 ± 3%, and 30 ± 3% in the ND, CDM, and UDM groups, respectively (P > .05). At baseline (pre-CPB), the difference in relaxation responses to the endothelium-dependent vasodilator substance P was insignificant between the ND and CDM groups (Fig 4, A and B, respectively) . However, the relaxation response of the UDM vessels were diminished significantly compared with that of ND or CDM groups (P < .05, Fig 4, A-C) . The post-CPB responses to substance P were significantly diminished in all 3 groups (P < .05 versus pre-CPB), but the reduction was greater in the UDM group than the ND or CDP groups (P < .05, Fig 4) .
DISCUSSION
Cellular junctions, particularly the adherens junctions play important roles in vascular permeability and endothelial barrier function. [9] [10] [11] [12] [13] [14] [15] Adherens junctions are key components in cellular adhesion between endothelial cells and are composed of transmembrane VE-cadherins that form the extracellular connections between vascular endothelial cells and catenins that link the intracellular portion of the cadherin proteins to the cytoskeleton. [9] [10] [11] [12] [13] [14] [15] Alterations in the VEcadherin complex have been demonstrated to result in increased vascular permeability and edema formation. [9] [10] [11] [12] [13] [14] [15] We have shown previously that in a porcine model, CPB causes downregulation of adherens junction proteins resulting in the loss of the integrity of coronary endothelium. 14, 15 The present study demonstrated that CPB induced phosphorylation of VE-cadherin and degradation of b-catenins in peripheral skeletal muscle and arterioles in patients early after CPB. These findings are consistent with previous studies, in which cardioplegia and CPB resulted in downregulation of adherens junction proteins in porcine and human myocardium and coronary arterioles. 8, 14, 15 These findings suggest that CPB has an important effect on the assembly of endothelial cadherin and thus the integrity of endothelial cells in human skeletal muscle.
Diabetes is associated with increased microvascular dysfunction as well as with increased morbidity and mortality after CPB and heart operation. [1] [2] [3] [4] [5] 8, 16, 17 Recently, we demonstrated that uncontrolled diabetes induced inactivation and reduction in adherens junction proteins in human atrial myocardium and coronary arteriolar endothelium. 8 Uncontrolled diabetes caused more VE-cadherin phosphorylation and b/g-catenin degradation of coronary vasculature early after cardioplegic ischemia and reperfusion. In this study, we observed that uncontrolled diabetes also downregulated expression of endothelial adherens junction proteins in the arterioles of skeletal muscle early after CPB. Although no significant changes in total VE-cadherin protein were observed between poorly controlled and well-controlled diabetics, the enhanced phosphorylation of VEcadherin and degradation of b-catenin suggest more protein deterioration and damage of endothelial junctions in the uncontrolled diabetic vessels. 8 These alterations may contribute to the increases in peripheral vascular permeability, tissue edema, and endothelial dysfunction of peripheral arterioles in uncontrolled diabetic patients. In addition, no differences in phosphorylation/ degradation of VE-cadherin and b-catenin between well-controlled diabetes and nondiabetics post-CPB suggest that relatively long-term control of hyperglycemia might be beneficial for preserving microvascular endothelial integrity.
Several factors are found to induce vascular permeability via a VE-cadherin-dependent mechanism, such as tumor necrosis factor, VEGF, histamine, neutrophil-associated proteases, oxygen radicals, and thrombin.
1,18-20 CPB and cardiac operation cause a different regulation of specific genes in the myocardium of nondiabetic and diabetic patients. 1, 21 Importantly, we also have demonstrated that the expression of permeability-modulating proteins, such as VEGF and vascular permeability factor, are enhanced in diabetic patients early after CPB and cardiac operation. 1, 6 These alterations may contribute to diabetes-induced downregulation of adherens junction proteins. These findings may explain in part why diabetes increased vascular permeability, endothelial dysfunction, and edema formation in peripheral tissue and delayed recovery in diabetic patients from CPB and cardiac operation. 1, 16, 17, 21 In conclusion, our results suggest that uncontrolled diabetes causes inactivation and reduction in the expression of endothelial adherens junction protein in the arterioles of skeletal muscle early after CPB. These alterations may contribute to the increases in peripheral vascular permeability and microvascular endothelial dysfunction.
